Toth I - Search Results

1

Toward the development of a synthetic group a streptococcal vaccine of high purity and broad protective coverage.

Horváth A, Olive C, Karpati L, Sun HK, Good M, Toth I. Horváth A, et al. Among authors: toth i. J Med Chem. 2004 Jul 29;47(16):4100-4. doi: 10.1021/jm040041w. J Med Chem. 2004. PMID: 15267249

2

The intersubunit region of the influenza virus haemagglutinin is recognized by antibodies during infection.

Nagy Z, Rajnavölgyi E, Hollósi M, Tóth GK, Váradi G, Penke B, Tóth I, Horváth A, Gergely J, Kurucz I. Nagy Z, et al. Among authors: toth gk, toth i. Scand J Immunol. 1994 Sep;40(3):281-91. doi: 10.1111/j.1365-3083.1994.tb03464.x. Scand J Immunol. 1994. PMID: 8091127

3

Novel lipoamino acid- and liposaccharide-based system for peptide delivery: application for oral administration of tumor-selective somatostatin analogues.

Tóth I, Malkinson JP, Flinn NS, Drouillat B, Horváth A, Erchegyi J, Idei M, Venetianer A, Artursson P, Lazorova L, Szende B, Kéri G. Tóth I, et al. J Med Chem. 1999 Sep 23;42(19):4010-3. doi: 10.1021/jm9910167. J Med Chem. 1999. PMID: 10508449

4

Lipid, sugar and liposaccharide based delivery systems.

Wong A, Toth I. Wong A, et al. Among authors: toth i. Curr Med Chem. 2001 Jul;8(9):1123-36. doi: 10.2174/0929867013372535. Curr Med Chem. 2001. PMID: 11472244 Review.

5

Lipoamino acid-based adjuvant carrier system: enhanced immunogenicity of group a streptococcal peptide epitopes.

Horvath A, Olive C, Wong A, Clair T, Yarwood P, Good M, Toth I. Horvath A, et al. Among authors: toth i. J Med Chem. 2002 Mar 14;45(6):1387-90. doi: 10.1021/jm0110441. J Med Chem. 2002. PMID: 11882009

6

Enhancing the immunogenicity and modulating the fine epitope recognition of antisera to a helical group A streptococcal peptide vaccine candidate from the M protein using lipid-core peptide technology.

Hayman WA, Toth I, Flinn N, Scanlon M, Good MF. Hayman WA, et al. Among authors: toth i. Immunol Cell Biol. 2002 Apr;80(2):178-87. doi: 10.1046/j.1440-1711.2002.01067.x. Immunol Cell Biol. 2002. PMID: 11940119

7

A lipid core peptide construct containing a conserved region determinant of the group A streptococcal M protein elicits heterologous opsonic antibodies.

Olive C, Batzloff MR, Horváth A, Wong A, Clair T, Yarwood P, Toth I, Good MF. Olive C, et al. Among authors: toth i. Infect Immun. 2002 May;70(5):2734-8. doi: 10.1128/IAI.70.5.2734-2738.2002. Infect Immun. 2002. PMID: 11953422 Free PMC article.

8

Technological advances in antigen delivery and synthetic peptide vaccine developmental strategies.

Olive C, Toth I, Jackson D. Olive C, et al. Among authors: toth i. Mini Rev Med Chem. 2001 Nov;1(4):429-38. doi: 10.2174/1389557013406666. Mini Rev Med Chem. 2001. PMID: 12369968 Review.

9

Synthesis, structure elucidation, in vitro biological activity, toxicity, and Caco-2 cell permeability of lipophilic analogues of alpha-conotoxin MII.

Blanchfield JT, Dutton JL, Hogg RC, Gallagher OP, Craik DJ, Jones A, Adams DJ, Lewis RJ, Alewood PF, Toth I. Blanchfield JT, et al. Among authors: toth i. J Med Chem. 2003 Mar 27;46(7):1266-72. doi: 10.1021/jm020426j. J Med Chem. 2003. PMID: 12646037

10

Potential of lipid core peptide technology as a novel self-adjuvanting vaccine delivery system for multiple different synthetic peptide immunogens.

Olive C, Batzloff M, Horváth A, Clair T, Yarwood P, Toth I, Good MF. Olive C, et al. Among authors: toth i. Infect Immun. 2003 May;71(5):2373-83. doi: 10.1128/IAI.71.5.2373-2383.2003. Infect Immun. 2003. PMID: 12704107 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,009 results

Search Page

Filters